Kchour, G., Tarhini, M., Kooshyar, M.M., El Hajj, H., Wattel, E., Mahmoudi, M., Hatoum, H., Rahimi, H., Maleki, M., Rafatpanah, H., Rezaee, S.A., Yazdi, M.T., Shirdel, A., de Thé, H., Hermine, O., Farid, R. and Bazarbachi, A. (2009) Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leuke-mia/lymphoma (ATL). Blood, 113, 6528-6532.
http://dx.doi.org/10.1182/blood-2009-03-211821
被以下文章引用:
-
标题:
腺样囊性癌的化学治疗Chemotherapy for the Treatment of Adenoid Cystic Carcinoma
作者:
姜涛, 姜靖, 王仁萍, 肖利华, 王毅
关键字:
腺样囊性癌, 化学治疗Adenoid Cystic Carcinoma (ACC), Chemotherapy
期刊名称:
《Hans Journal of Ophthalmology》, Vol.4 No.3, 2015-09-28
摘要:
腺样囊性癌(adenoid cystic carcinoma, ACC)恶性程度高，其特征为缓慢地局部浸润性生长，易局部复发与远处转移，预后差，难根治，死亡率较高，于眼眶部好发于泪腺，其临床治疗一直以来就是一个难点。传统的治疗方法包括手术切除、放射治疗、化学治疗及上述方式的联合应用等综合治疗方法。大部分ACC的初发病例采用手术切除治疗，然后行放射治疗，对于复发病例，治疗选择有限，再次放疗与重复手术切除的治疗效果有限。近年来，ACC的化学治疗研究逐渐为人们所重视，本文将其研究的进展情况进行综述。
Adenoid cystic carcinoma (ACC) is a malignant tumor, and its malignant degree is high, the cha-racteristics of which is slow local invasive growth, easy to local recurrence and distant metastasis, with poor prognosis and high mortality, difficult to cure. In orbit it occurs in the lacrimal gland. The clinical treatment has been a difficulty. Traditional treatment methods include surgery, radi-otherapy, chemotherapy, and the combination of the above methods. Most of ACC's primary cases were treated with surgical resection, followed by radiation therapy. For the treatment of recurrent cases, options are limited, and the effect of re-radiation therapy and repeat surgery is limited. In recent years, the research on the chemotherapy for ACC is gradually paid attention to. In this paper, the progress of the research is summarized.